Forte Biosciences, Inc. logo

Forte Biosciences, Inc. (FBRX)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
48. 86
+3.87
+8.6019%
$
609.86M Market Cap
- P/E Ratio
- Div Yield
595,800 Volume
- Eps
$ 44.99
Previous Close
Investors:
Add Transaction
Day Range
42 50
Year Range
9.1 50
Want to track FBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Forte Biosciences, Inc. (FBRX) Statistics

Valuation metrics

Market Cap 609.86M
Enterprise value 620.23M
Trailing P/E (ttm) -10.67
Forward P/E -7.14
PEG ratio -0.11
Price/Sales (ttm) -
Price/Book (mrq) 207.02
Enterprise Value/Revenue -
Enterprise Value/EBITDA -8.34

Overview

Shares outstanding 12.95M
Float 17.32M
Shares short 892.18K
% Held by insiders 0.02%
% Held by institutions 0.67%
Average volume (10 days) 595.67K
Average volume (90 days) 337.01K

Price summary

52-Week low 9.1
52-Week high 50
Beta 3.2
50-Day moving average 23.17
200-Day moving average 27.76

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 28 Aug 2024

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.13%
Return on equity -1.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -70.59M
Net income to common (ttm) -69.38M
Diluted EPS (ttm) -0.43
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 76.96M
Total cash per share (mrq) 0.33
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.75%
Book value per share (mrq) 0.24

Cash Flow

Cash flow statement -50.88M
Levered free cash flow (LFCF) -26.94M